Cargando…

Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study

SIMPLE SUMMARY: Serum C-reactive protein (CRP) is an established biomarker for acute inflammation and has been identified as a prognostic indicator for hepatocellular carcinoma (HCC). It is especially important to verify the utility of CRP in HCC patients treated with lenvatinib because the benefits...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okumura, Taiki, Kimura, Takefumi, Iwadare, Takanobu, Wakabayashi, Shun-ichi, Kobayashi, Hiroyuki, Yamashita, Yuki, Sugiura, Ayumi, Joshita, Satoru, Fujimori, Naoyuki, Kunimoto, Hideo, Komatsu, Michiharu, Fukushima, Hideki, Mori, Hiromitsu, Umemura, Takeji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670047/ https://www.ncbi.nlm.nih.gov/pubmed/38001602 http://dx.doi.org/10.3390/cancers15225343

Ejemplares similares

Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD
por: Iwadare, Takanobu, et al.
Publicado: (2022)

Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
por: Kimura, Takefumi, et al.
Publicado: (2018)

Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients
por: Iwadare, Takanobu, et al.
Publicado: (2022)

Pyogenic liver abscess associated with Klebsiella oxytoca: Mimicking invasive liver abscess syndrome
por: Iwadare, Takanobu, et al.
Publicado: (2023)

Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
por: Fujimori, Naoyuki, et al.
Publicado: (2018)

KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients
por: Saito, Hiromi, et al.
Publicado: (2018)

Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C
por: Yamazaki, Tomoo, et al.
Publicado: (2017)

Symptom‐based portopulmonary hypertension screening questionnaire in Japanese patients with chronic liver disease
por: Wakabayashi, Shun‐Ichi, et al.
Publicado: (2023)

Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis
por: Sekiguchi, Tomohiro, et al.
Publicado: (2015)

Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease
por: Shibata, Soichiro, et al.
Publicado: (2016)

Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study
por: Umemura, Takeji, et al.
Publicado: (2019)

Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection
por: Joshita, Satoru, et al.
Publicado: (2019)

Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C
por: Yamazaki, Tomoo, et al.
Publicado: (2018)

Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in a Patient with Chronic Hepatitis B Virus Infection: Case Report and Summary of the Literature
por: Yamashita, Yuki, et al.
Publicado: (2021)

Association between endotoxemia and histological features of nonalcoholic fatty liver disease
por: Kitabatake, Hiroyuki, et al.
Publicado: (2017)

Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan
por: Umemura, Takeji, et al.
Publicado: (2014)

Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis
por: Joshita, Satoru, et al.
Publicado: (2018)

Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients
por: Joshita, Satoru, et al.
Publicado: (2021)

Investigation of the Effect of KIR–HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients
por: Umemura, Takeji, et al.
Publicado: (2021)

Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease
por: Wakabayashi, Shun-ichi, et al.
Publicado: (2021)

KIR, HLA, and IL28B Variant Predict Response to Antiviral Therapy in Genotype 1 Chronic Hepatitis C Patients in Japan
por: Nozawa, Yuichi, et al.
Publicado: (2013)

Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan
por: Umemura, Takeji, et al.
Publicado: (2016)

STAT4 Gene Polymorphisms Are Associated with Susceptibility and ANA Status in Primary Biliary Cirrhosis
por: Joshita, Satoru, et al.
Publicado: (2014)

Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis
por: Yamashita, Yuki, et al.
Publicado: (2022)

Salmonella Enteritidis cholecystitis with chronic granulomatous disease
por: Yamashita, Yuki, et al.
Publicado: (2018)

Protocol: Prospective observational study aiming for micro-elimination of hepatitis C virus in Nagawa town: The Nagawa Project
por: Kobayashi, Hiroyuki, et al.
Publicado: (2021)

Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases
por: Sugiura, Ayumi, et al.
Publicado: (2020)

A case report of pancreatic panniculitis due to acute pancreatitis with intraductal papillary mucinous neoplasm
por: Yamashita, Yuki, et al.
Publicado: (2020)

Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy
por: Nagaya, Tadanobu, et al.
Publicado: (2015)

Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
por: Joshita, Satoru, et al.
Publicado: (2017)

An Autopsy Case of Primary Biliary Cholangitis with Histological Submassive Hepatic Necrosis Caused by Acute Hepatitis E Virus Infection
por: Koyama, Mizuki, et al.
Publicado: (2021)

Current status, problems, and perspectives of non-alcoholic fatty liver disease research
por: Tanaka, Naoki, et al.
Publicado: (2019)

Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma
por: Sasaki, Ryu, et al.
Publicado: (2022)

A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis
por: Yamazaki, Tomoo, et al.
Publicado: (2018)

A Case of Adult T-Cell Leukemia/Lymphoma Complicated with Bilateral Chylothorax
por: Kako, Satoko, et al.
Publicado: (2019)

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
por: Personeni, Nicola, et al.
Publicado: (2019)

Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2021)

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma
por: Amioka, Kei, et al.
Publicado: (2022)

Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
por: Finn, Richard S., et al.
Publicado: (2020)

Relationship of early acute complications and insertion site in push method percutaneous endoscopic gastrostomy
por: Suzuki, Hiroshi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_91iptgbv1bv090p0ntev7cauvo